Skip to main content
Clinical Trials/CTRI/2021/01/030363
CTRI/2021/01/030363Completed未知

Assessment of serological response to COVID-19 and its association with exposure to MR-containing vaccine: A pilot study

niversity College of Medical Sciences0 sites90 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
90

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Group 1: COVID-19 positive children who have received MR-containing vaccine atleast 6 weeks before date of enrolment
  • Group 2: COVID 19 positive children who have not received MR containing vaccine

Exclusion Criteria

  • Children with past infection due to measles or rubella, immunodeficiency states (both primary and secondary), chronic diseases (congenital heart disease, respiratory diseases that cause pulmonary function impairment, hypothyroidism, IDDM), history of blood transfusion within last 3 months, severe malnutrition (wt-for-ht <-3SD, MUAC <11.5cm, or bilateral pedal edema of nutritional origin), malignancy

Investigators

Sponsor
niversity College of Medical Sciences

Similar Trials

Serological response to COVID-19 and... | Clinical Trial